It is tough out there for biotech companies. The rewards can be big, but the time frames are long and the risks are high. Research Triangle Park-based is the latest hope for the area鈥檚 biotech scene.
The company went public last week, sparking hope that local investments in the company鈥檚 proposed cancer drug pay off. Host Frank Stasio talks with 瓜神app data reporter about what a win would mean for the Triangle鈥檚 biotech scene and other industry news.
